Calcium Citrate Malate (250mg), Vitamin D3/Cholecalciferol (400IU), Vitamin K1/Phylloquinone (45mcg), Magnesium (40mg)
Centrum Ostocalcium CCM Tablet is an advanced bone-matrix and vascular-remodeling formula engineered to maximize bone mineral density and direct calcium into skeletal structures while protecting arteries from calcification.
Supplies premium Calcium Citrate Malate and Vitamin D3 to maximize bone mineral density with superior intestinal absorption and zero stomach irritation; utilizes Vitamin K1 to guide circulating calcium directly into bone crystals while actively keeping it out of cardiovascular arterial walls; and incorporates Magnesium to optimize neuromuscular signaling, preventing muscle cramps and stiffness.
Swallow the tablet whole with a glass of water. Thanks to the highly water-soluble Calcium Citrate Malate form, this tablet can be taken comfortably at any time of day, completely independent of food (either on an empty stomach or after a primary meal). However, if you are looking to maximize the biological absorption of its fat-soluble Vitamin D3 and Vitamin K1 components, taking it strictly with or immediately after your largest meal of the day is highly recommended. Do not chew, break, or crush the tablet shell. Maintain a baseline separation of at least 2 to 4 hours if you are concurrently taking iron supplements, antacids, thyroid hormones (levothyroxine), or certain antibiotics (such as quinolones or tetracyclines), as calcium can form insoluble complexes that severely restrict their absorption.
Extremely mild temporary abdominal gas or minor bloating, Mild constipation (significantly less frequent than with standard calcium carbonate forms), Mild nausea or minor stomach discomfort if taken empty-stomached by highly sensitive individuals
Caution
Safe If Prescribed
Safe
Caution
Safe If Prescribed
Drogheria Sellers Private Limited
Brigade IRV, 9th & 10th Floors, Nallurhalli, White Field, Bangalore, Banglore, Karnataka, India, 560066 For Support ReachOut : support+drogheria@zeptonow.com
MH-MZ3-615802, MH-MZ3-615803
GSK
India
18 months
December 2026